Ms. Olson, it's very nice meeting you again.
I recall that when you and a couple of your members came to meet me, we discussed various programs. As you said, we do have excellent programs for innovation and research and development, the SR and ED, IRAP, etc. If I recall, we did mention the problems in funding of commercialization, as you mentioned here, the production and marketing costs of new innovation products.
Could you quickly elaborate on that?